Privia Health Group, Inc.

NASDAQ:PRVA

22.8 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 480.097460.9437.921422.326415.243440.828417.282413.351386.276364.424342.899335.536313.801275.333251.524225.756213.607213.699207.17183.264212.942
Cost of Revenue 434.335412.933392.569379.642374.393401.787375.546371.918346.985327.711309.013301.695283.459250.446225.369238.668188.075190.301185.673165.852192.667
Gross Profit 45.76247.96745.35242.68440.8539.04141.73641.43339.29136.71333.88633.84130.34224.88726.155-12.91225.53223.39821.49717.41220.275
Gross Profit Ratio 0.0950.1040.1040.1010.0980.0890.10.10.1020.1010.0990.1010.0970.090.104-0.0570.120.1090.1040.0950.095
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 31.72134.42530.69528.91632.12129.627.22826.80825.95128.15632.21933.10736.1139.32133.91168.65713.99614.829.7888.41910.989
Selling & Marketing Expenses 6.9226.4627.0476.8526.0856.2497.2415.9565.2865.1735.0884.8194.6613.84.58811.1783.1843.9622.7092.222.452
SG&A 38.64340.88737.74235.76838.20635.84934.46932.76431.23733.32937.30737.92640.77143.12138.498179.83517.1818.78212.49710.63913.441
Other Expenses 1.9011.8321.7971.8181.8211.7721.7311.691.341.1351.153302.861.1181.1130.4660.440.4450.4540.4570.5940.338
Operating Expenses 40.54442.71939.53937.58640.02737.62136.234.45432.57734.46438.4639.09141.88944.23438.964180.27517.62519.23612.95411.23313.779
Operating Income 5.2185.2485.8135.0980.8231.425.5366.9796.7142.249-4.574-5.25-11.547-19.347-12.809-193.1877.9074.1628.5436.1796.496
Operating Income Ratio 0.0110.0110.0130.0120.0020.0030.0130.0170.0170.006-0.013-0.016-0.037-0.07-0.051-0.8560.0370.0190.0410.0340.031
Total Other Income Expenses Net 2.9312.7742.1642.9662.9842.8482.8940.8171.8131.1520.285-0.663-0.232-0.185-0.292-0.302-0.291-0.437-0.504-0.509-0.467
Income Before Tax 8.1498.0227.9778.0643.8074.2688.437.7968.5273.401-4.289-5.913-11.779-19.532-13.101-193.4897.6163.7258.0395.676.029
Income Before Tax Ratio 0.0170.0170.0180.0190.0090.010.020.0190.0220.009-0.013-0.018-0.038-0.071-0.052-0.8570.0360.0170.0390.0310.028
Income Tax Expense 2.1032.6553.9993.4210.7511.9442.4881.4362.125-13.447-4.8455.4686.308-7.643-2.21-20.0042-0.054-8.5610.4740.7
Net Income 4.224.3993.5353.4672.9842.8385.6437.2747.32417.7760.556-10.475-18.087-11.979-9.115-172.5345.3983.86416.6855.2815.414
Net Income Ratio 0.0090.010.0080.0080.0070.0060.0140.0180.0190.0490.002-0.031-0.058-0.044-0.036-0.7640.0250.0180.0810.0290.025
EPS 0.030.0370.030.030.030.020.050.060.060.160.005-0.096-0.17-0.11-0.09-1.680.0520.0380.160.0510.053
EPS Diluted 0.030.0350.030.030.020.020.050.060.060.140.005-0.096-0.17-0.11-0.086-1.680.0520.0380.160.0510.053
EBITDA 7.1197.087.616.9162.6443.1927.2678.6698.0543.384-3.421-4.085-10.429-18.234-12.342-192.7478.3524.6169.0016.7736.834
EBITDA Ratio 0.0150.0150.0170.0160.0060.0070.0170.0210.0210.009-0.01-0.012-0.033-0.066-0.049-0.8540.0390.0220.0430.0370.032